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Abstract
Background: Interleukin (IL)-6 plays a pivotal role in a variety of CNS functions such as the induction and
modulation of reactive astrogliosis, pathological inflammatory responses and neuroprotection. Tumor necrosis
factor (TNF)-a induces IL-6 release from rat C6 glioma cells through the inhibitory kappa B (IB)-nuclear factor
kappa B (NFB) pathway, p38 mitogen-activated protein (MAP) kinase and stress-activated protein kinase (SAPK)/
c-Jun N-terminal kinase (JNK). The present study investigated the mechanism of TNF-a-induced IL-6 release in
more detail than has previously been reported.
Methods: Cultured C6 cells were stimulated by TNF-a. IL-6 release from the cells was measured by an enzyme-
linked immunosorbent assay, and the phosphorylation of IB, NFB, the MAP kinase superfamily, and signal
transducer and activator of transcription (STAT)3 was analyzed by Western blotting. Levels of IL-6 mRNA in cells
were evaluated by real-time reverse transcription-polymerase chain reaction.
Results: TNF-a significantly induced phosphorylation of NFB at Ser 536 and Ser 468, but not at Ser 529 or Ser
276. Wedelolactone, an inhibitor of IB kinase, suppressed both TNF-a-induced IB phosphorylation and NFB
phosphorylation at Ser 536 and Ser 468. TNF-a-stimulated increases in IL-6 levels were suppressed by
wedelolactone. TNF-a induced phosphorylation of STAT3. The Janus family of tyrosine kinase (JAK) inhibitor I, an
inhibitor of JAK 1, 2 and 3, attenuated TNF-a-induced phosphorylation of STAT3 and significantly reduced TNF-a-
stimulated IL-6 release. Apocynin, an inhibitor of NADPH oxidase that suppresses intracellular reactive oxygen
species, significantly suppressed TNF-a-induced IL-6 release and mRNA expression. However, apocynin failed to
affect the phosphorylation of IB, NFB, p38 MAP kinase, SAPK/JNK or STAT3.
Conclusion: These results strongly suggest that TNF-a induces IL-6 synthesis through the JAK/STAT3 pathway in
addition to p38 MAP kinase and SAPK/JNK in C6 glioma cells, and that phosphorylation of NFB at Ser 536 and Ser
468, and NADPH oxidase are involved in TNF-a-stimulated IL-6 synthesis.
Background
Tumor necrosis factor (TNF)-a is a potent pro-inflam-
matory cytokine with a major role in initiating a cascade
of activation of other cytokines and growth factors in
inflammatory responses [1]. TNF-a is synthesized by
microglia, astrocytes and some populations of neurons
and has several important functions in the CNS, includ-
ing injury-mediated microglial and astrocyte activation,
regulation of blood-brain barrier permeability, febrile
responses, glutamatergic transmission, and synaptic plas-
ticity [2]. TNF-a leads to activation of inhibitory kappa
B( I B) by the IB kinase (IKK) complex, which in turn
leads to IB polyubiquitination and subsequent degrada-
tion by proteasome [3]. Consequently, nuclear factor
kappa B (NFB) is phosphorylated, liberated from IB
and translocates to the nucleus, where it binds to the
promoter regions of NFB responsive genes and initiates
transcription of genes such as those for the proinflam-
matory cytokines interleukin (IL)-6, IL-1, and TNF-a
[1,3]. Each member of NFB family, such as p65, c-REL,
RELB, p105/p50 and p100/p52, can form homodimers,
as well as heterodimers with one another. The main
activated form of NFB is a heterodimer of the p65 sub-
unit [1,3]. Different phosphorylation patterns may
recruit different transcriptional cofactors to the subunit
and induce distinct profiles of gene expression [3]. TNF-
a induces IL-6 release through the phosphorylation of
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stress-activated protein kinase (SAPK)/c-Jun N-terminal
kinase (JNK) in rat C6 glioma cells [4]. TNF-a induces
IL-6 expression through the p65 phosphorylation at Ser
276, but not at Ser 529 or Ser 536 in murine fibroblasts
[5]. However, the details of NFB phosphorylation in
glial cells have not been clarified.
In addition to the IB-NFB pathway, the main intra-
cellular signaling pathway activated by cytokines is the
Janus family of tyrosine kinase (JAK)-signal transducer
and activator of transcription (STAT) pathway. The acti-
vation of the JAK-STAT pathway leads to a rapid signal-
ing from the cell surface to the nucleus [6]. JAK
proteins are phosphorylated when cytokines bind to spe-
cific receptors, and subsequently activate STATs. The
activated STATs translocate to the nucleus and transmit
the signals, where they then bind to specific consensus
sequences, thereby triggering gene transcription [6].
Seven STAT proteins have been identified in mamma-
lian cells [6]. Among them, STAT1 and STAT3 play
important roles in post-ischemic brain damage [7,8]. IL-
1b, an important cytokine, phosphorylates STAT3 in C6
cells [9]. However, the precise role of the JAK-STAT
pathway in glial cells remains to be elucidated.
Oxidative stress refers to a state with elevated levels of
intracellular reactive oxygen species (ROS; such as
superoxide radicals and hydrogen peroxide) production
and impaired function of antioxidant defense mechan-
isms. NADPH oxidase is a multi-subunit enzyme that
catalyzes the reduction of molecular oxygen and the oxi-
dation of NADPH to generate superoxide radicals [10].
NADPH oxidase is widely distributed and has a variety
of functions, such as regulation of immune system, cell
growth, cell death and endothelial functions. While
NADPH oxidase-derived ROS are necessary for normal
cellular functions, excessive oxidative stress can contri-
bute to pathological conditions. ROS play critical roles
in TNF-a signaling [11]. NFBa c t sa sas u p p r e s s o ro f
intracellular ROS formation in TNF-a treated cells [11].
Crosstalk occurs between JNK and NFB, and a role for
ROS in TNF-a signaling has emerged. The intermediacy
of ROS in the crosstalk between JNK and NFBi s ;1 )a
TNF-a-induced increase in intracellular ROS is respon-
sible for sustained JNK activation, as well as impaired
NFB activation; 2) NFB regulates the expression of
several key antioxidant enzymes or proteins to eliminate
ROS, thus serving as a negative feedback loop; and 3)
activated JNK is capable of promoting ROS production,
thus forming a positive feedback loop between JNK and
ROS [11]. NADPH oxidase in the CNS is associated
with memory, neurodegenerative diseases, cerebral
ischemic injury and central regulation of the cardiovas-
cular system [10]. NADPH oxidase is found mainly in
neurons [12]. Amyloid b induces NADPH oxidase
activation and causes oxidative stress in astrocytes [13].
However, the role of NADPH oxidase in astrocytes
remains to be fully clarified.
The present study investigated the phosphorylation of
specific residues of NFB is association with TNF-a-sti-
mulated IL-6 synthesis in C6 glioma cells. Furthermore,
the involvement of the JAK-STAT pathway and
NADPH oxidase in the TNF-a-stimulated IL-6 synthesis
was examined.
Methods
Materials
TNF-a was obtained from Peprotech (London, UK). IL-
6 enzyme-linked immunosolvent assay (ELISA) kit was
purchase from R&D System (Minneapolis, MN). Wede-
lolactone, JAK inhibitor I and apocynin were obtained
from Calbiochem-Novabiochem Co. (La Jolla, CA).
Phospho-specific IB, IB, phospho-specific NFB( S e r
536, Ser 468 and Ser 276), NFB, phospho-specific p38
MAP kinase, p38 MAP kinase, phospho-specific SAPK/
JNK, SAPK/JNK, phospho-specific STAT3, STAT3 and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
antibodies were purchased from Cell Signaling Technol-
ogy (Beverly, MA). Phospho-specific NFB( S e r5 2 9 )
antibody was purchased from abcam (Cambridge, MA).
An enhanced chemiluminescence Western blotting
detection system was obtained from GE Healthcare UK.
Ltd. (Buckinghamshire, England). Other materials and
chemicals were obtained from commercial sources.
Wedelolactone and JAK inhibitor I were dissolved in
dimethyl sulfoxide. Apocynin was dissolved in ethanol.
The maximum concentration of dimethyl sulfoxide or
ethanol was 0.1%, which did not affect either the assay
for IL-6, the Western blot analysis or the mRNA
expression.
Cell culture
Rat C6 glioma cells, obtained from the American Type
Culture Collection (Rockville, MD), were seeded into
35-mm (5 × 10
4 cells/dish) or 90-mm (2 × 10
5 cells/
dish) diameter dishes and maintained in Dulbecco’s
modified Eagle’s medium (DMEM) containing 10% fetal
bovine serum at 37°C in a humidified atmosphere of 5%
CO2/95% air. The medium was exchanged for serum-
free DMEM after 6 days. The cells were then used for
experiments after 24 h. The cells were pretreated with
wedelolactone, JAK inhibitor I or apocynin for 60 min
before TNF-a stimulation when indicated.
Assay for IL-6
Cultured cells (35-mm diameter dishes) were stimulated
with 10 ng/ml TNF-a in serum-free DMEM for 36 h.
The conditioned medium was collected at the end of
the incubation, and IL-6 concentration was measured
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450 nm and 540 nm was measured with a Multiscan JX
ELISA reader (Thermo Labsystems, Helsinki, Finland).
Absorbance was corrected with reference to a standard
curve.
Western blot analysis
Cultured cells (90-mm diameter dishes) were stimulated
with 10 ng/ml TNF-a in serum-free DMEM for the
indicated periods. The cells were washed twice with
phosphate-buffered saline and then lysed and sonicated
in a lysis buffer containing 62.5 mM Tris/HCl (pH 6.8),
2% sodium dodecyl sulfate (SDS), 50 mM dithiothreitol,
and 10% glycerol. The sample was used for the Western
blotting analysis as described previously [9]. The sam-
ples were separated by SDS-polyacrylamide gel electro-
phoresis by the method of Laemmli [14] in 10%
polyacrylamide gels. Western blot analysis was per-
formed using phospho-specific IB antibodies, IBa n t i -
bodies, phospho-specific NFB antibodies, NFB
antibodies, phospho-specific p38 MAP kinase antibodies,
p38 MAP kinase antibodies, phospho-specific SAPK/
JNK antibodies, SAPK/JNK antibodies, phospho-specific
STAT3 antibodies, STAT3 antibodies or GAPDH anti-
bodies, with peroxidase-labeled antibodies raised in goat
against rabbit IgG being used as second antibodies. Per-
oxidase activity on polyvinylidene difluoride membrane
was visualized on X-ray film by utilizing an enhanced
chemiluminescence Western blotting detection system.
Real-time reverse transcription (RT)-polymerase chain
reaction (PCR)
Cultured cells (35-mm diameter dishes) were stimulated
with 10 ng/ml TNF-a for the indicated periods. Total
RNA was isolated and transcribed into complementary
DNA (cDNA) using Trizol reagent and Omniscript
Reverse Transcriptase Kit. Real-time PCR was per-
formed using a Light Cycler system (Roche Diagnostics,
Basel, Switzerland) in the capillaries and Fast-Start DNA
Master SYBR Green I provided with the kit. Sense and
antisense primers for mouse IL-6 or GAPDH mRNA
were purchased from Takara Bio Inc. (Tokyo, Japan)
(primer set ID:MA039013). The amplified products were
determined by a melting curve analysis and agarose
electrophoresis. IL-6 mRNA levels were normalized with
those of GAPDH mRNA.
Statistical analysis
The data were analyzed by ANOVA followed by Bonfer-
roni’s method for multiple comparisons between pairs.
P < 0.05 was considered to be significant. All data are
presented as the mean ± SD of triplicate determinations.
Each experiment was repeated three times with similar
results.
Results
Effect of TNF-a on IB and NFB phosphorylation in
C6 cells
The IB-NFB pathway is involved in TNF-a-induced
IL-6 release from C6 glioma cells [4]. NFB binds to its
consensus sequence on a target gene promoting tran-
scription and upregulation of gene expression [3]. The
phosphorylation of NFB at different sites shows differ-
ent gene expressions [3]. The effects of TNF-a on the
phosphorylation of four serine residues (Ser 536, Ser
529 and Ser 468, Ser 276) were examined. TNF-a signif-
icantly induced phosphorylation of NFB at Ser 536 and
Ser 468 in a time-dependent manner. Ser 536 phosphor-
ylation was observed at 5 min and decreased after 20
min, and Ser 468 phosphorylation was enhanced at 5
min and maintained a plateau for up to 30 min (Fig. 1).
On the contrary, Ser 529 and Ser 276 were phosphory-
lated in unstimulated cells, but they were not affected
by TNF-a stimulation.
Figure 1 Effects of TNF-a on IB phosphorylation and
degradation and NFB phosphorylation. Cultured cells were
stimulated with 10 ng/ml TNF-a for the indicated period. Cell
extracts were analyzed by Western blotting using antibodies against
phospho-specific IB, IB, phospho-specific NFB, NFB or GAPDH.
Similar results were obtained with two additional and different cell
preparations.
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phosphorylation in C6 cells
Wedelolactone (30 μM), an inhibitor of IKK [15], sup-
pressed TNF-a-induced IB phosphorylation (Fig. 2).
In addition, phosphorylation of NFB at both Ser 536
and Ser 468 was inhibited by wedelolactone (Fig. 3).
Wedelolactone, which by itself had little effect on the
IL-6 levels, significantly suppressed TNF-a-induced IL-
6 release. The suppressive effect was concentration-
dependent in the range between 1 and 50 μM( F i g .4 ) .
Figure 2 Effects of wedelolactone on TNF-a-induced phosphorylation and degradation of IB. Cultured cells were pretreated with various
concentrations of wedelolactone or vehicle for 60 min, and then stimulated with 10 ng/ml TNF-a or vehicle for 10 min. Cell extracts were
analyzed by Western blotting using antibodies against phospho-specific IB, IB or GAPDH. Similar results were obtained with two additional
and different cell preparations.
Figure 3 Effects of wedelolactone on TNF-a-induced
phosphorylation of NFB. Cultured cells were pretreated with
various concentrations of wedelolactone or vehicle for 60 min, and
then stimulated with 10 ng/ml TNF-a or vehicle for 10 min. Cell
extracts were analyzed by Western blotting using antibodies against
phospho-specific NFBo rN F B. Similar results were obtained with
two additional and different cell preparations.
Figure 4 Effects of wedelolactone on TNF-a-induced IL-6
release. Cultured cells were pretreated with various concentrations
of wedelolactone for 60 min, and then stimulated with 10 ng/ml
TNF-a (closed circle) or vehicle (open circle) for 36 h. Each value
represents the mean ± SD of triplicate independent determinations
of a representative experiment carried out three times. Similar
results were obtained with two additional and different cell
preparations. *P < 0.05 in comparison to the value of TNF-a alone.
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from C6 cells
The JAK-STAT pathway has an essential role in driving
a variety of biological responses to cytokines [6]. The
effect of TNF-a on the phosphorylation of STAT3 was
examined. Phosphorylation of STAT3 was marked at
60 min, and reached a peak 150 min after stimulation
(Fig. 5). The effect of JAK inhibitor I, an inhibitor of
JAK 1, 2 and 3 [16], on TNF-a-induced IL-6 release was
examined. JAK inhibitor I (10 nM), which by itself had
little effect on the IL-6 levels, significantly suppressed
TNF-a-induced IL-6 release (Fig. 6A). In addition, JAK
inhibitor I truly suppressed TNF-a-induced phosphory-
lation of STAT3 in a concentration-dependent manner
Figure 5 Effects of TNF-a on STAT3 phosphorylation.C u l t u r e d
cells were stimulated with 10 ng/ml TNF-a for the indicated period.
Cell extracts were analyzed by Western blotting using antibodies
against phospho-specific STAT3 or STAT3. Similar results were
obtained with two additional and different cell preparations.
Figure 6 Effect of JAK inhibitor I on TNF-a-induced IL-6 release. (A) Cultured cells were pretreated with 10 nM JAK inhibitor I for 60 min,
and then stimulated with 10 ng/ml TNF-a or vehicle for 36 h. Each value represents the mean ± SD of triplicate independent determinations of
a representative experiment carried out three times. *P < 0.05 in comparison to the value of TNF-a alone. (B) Cultured cells were pretreated with
various concentrations JAK inhibitor I or vehicle for 60 min, and then stimulated with 10 ng/ml TNF-a or vehicle for 150 min. Cell extracts were
analyzed by Western blotting using antibodies against phospho-specific STAT3 or STAT3. Similar results were obtained with two additional and
different cell preparations.
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phosphorylation of STAT3 was observed later than
phosphorylation of IB, NFB or MAP kinases. This
delayed phosphorylation is consistent with a previous
report, showing that IL-1b phosphorylates STAT3
60 min after stimulation in C6 cells [9].
Effect of apocynin on TNF-a-induced IL-6 release
from C6 cells
Apocynin, an inhibitor of NADPH oxidase [17], which
by itself had little effect on IL-6 levels, significantly sup-
pressed TNF-a-induced IL-6 release (Fig. 7). This sup-
pressive effect was concentration-dependent in the
range between 1 and 100 μM. In addition, TNF-a
(10 ng/ml) significantly induced IL-6 mRNA expression at
6 h after stimulation (Fig. 8), thus suggesting that TNF-a
stimulates the synthesis of IL-6 in C6 glioma cells. The
suppressive effect of apocynin on IL-6 release by TNF-a
could be due to protein synthesis suppression. Apocynin
(100 μM) suppressed TNF-a-induced IL-6 mRNA
expression (Fig. 8). The effects of apocynin on TNF-a-
induced phosphorylation of IB, NFB, p38 MAP kinase,
SAPK/JNK or STAT3 were examined to determine
whether the apocynin-effect on TNF-a-induced-IL-6
release is dependent upon activation of the IB-NFB
pathway, the MAP kinase superfamily, and the JAK-
STAT3 pathway in C6 cells. However, apocynin failed to
affect the phosphorylation of these kinases (Fig. 9).
Discussion
TNF-a-induced IL-6 release is dependent on the IB-
NFB pathway [4]. Several sites in the N-terminal Rel
homology domain, including Ser 276, or in the C termi-
nus transactivation domain region play a pivotal role in
the finer regulation of NFB transcriptional activity [3].
Different phosphorylation patterns may induce distinct
profiles of gene expression [3]. Therefore, the present
study investigated which residue is involved in the TNF-
a-stimulated IL-6 synthesis in C6 glioma cells. TNF-a
significantly induced the phosphorylation of NFBa t
Ser 536 and Ser 468, but not at Ser 529 and Ser 276.
Ser 276 phosphorylation by TNF-a is essential for IL-6
production in murine fibroblasts [5]. However, Ser 276
is phosphorylated in unstimulated rat C6 glioma cells
and the levels do not change with TNF-a stimulation.
Furthermore, wedelolactone, an IKK inhibitor [15], truly
reduced the TNF-a-induced IL-6 release and NFB
Figure 7 Effect of apocynin on TNF-a-induced IL-6 release.
Cultured cells were pretreated with various concentrations apocynin
for 60 min, and then stimulated with 10 ng/ml TNF-a (closed circle)
or vehicle (open circle) for 36 h. Each value represents the mean ±
SD of triplicate independent determinations of a representative
experiment carried out three times. Similar results were obtained
with two additional and different cell preparations. *P < 0.05 in
comparison to the value of TNF-a alone.
Figure 8 Effect of apocynin on TNF-a-induced IL-6 mRNA
expression. Cultured cells were pretreated with 0.1 mM apocynin
or vehicle for 60 min, and then stimulated with 10 ng/ml TNF-a for
6 h. Total RNA was isolated and transcribed into cDNA. The
expressions of IL-6 mRNA and GAPDH mRNA were quantified by
real-time RT-PCR. IL-6 mRNA levels were normalized with those of
GAPDH mRNA. Each value represents the mean ± SD of triplicate
independent determinations of a representative experiment carried
out three times. Similar results were obtained with two additional
and different cell preparations. *P < 0.05 in comparison to the value
of unstimulated cells. **P < 0.05 in comparison to the value of TNF-
a alone.
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these findings suggest that TNF-a induces IL-6 release
through phosphorylation of NFBa tS e r5 3 6a n dS e r
468 in C6 glioma cells.
JAKs are constitutively associated with many cytokine
receptors [6]. The binding of cytokines to a receptor
associated with JAKs leads to the tyrosine phosphoryla-
tion of the receptor, and generates a docking site for
STATs [6]. The STATs are thus phosphorylated and
translocate to the nucleus where they may activate
transcription of several genes [6]. The present study
demonstrated that TNF-a significantly induced phos-
phorylation of STAT3 in C6 cells, and that JAK inhibi-
tor I, an inhibitor of JAK 1, 2 and 3 [16], suppressed
TNF-a-induced IL-6 release. In addition, JAK inhibitor I
suppressed TNF-a-induced STAT3 phosphorylation.
Therefore, these results suggest that TNF-a induces IL-
6r e l e a s et h r o u g ht h eJ A K - S T A T 3p a t h w a yi na d d i t i o n
to p38 MAP kinase and SAPK/JNK in C6 glioma cells.
Finally, apocynin, an inhibitor of NADPH oxidase [17],
significantly suppressed TNF-a-induced IL-6 release and
mRNA expression. The action point of NADPH oxidase
in TNF-a-stimulated IL-6 synthesis in C6 glioma cells
was investigated. However, apocynin did not affect
TNF-a-induced IB, NFB, p38 MAP kinase, SAPK/
JNK or STAT3 phosphorylation. It therefore seems unli-
kely that NADPH oxidase functions at a point of these
kinases in TNF-a-induced IL-6 synthesis in C6 glioma
cells. The current findings are consistent with a previous
report, in which ROS was said to be regulated by NFB
and JNK activation [11].
IL-6 plays a key role in B cell maturation and drives
acute inflammatory responses [18,19]. IL-6 is produced
in neurons, microglia and astrocytes, and it plays a pivo-
t a lr o l ei nav a r i e t yo fC N Sf u n c t i o n ss u c ha si n d u c t i o n
and modulation of reactive astrogliosis, pathological
inflammatory responses and neuroprotection [18,20].
Various stimuli, such as infection, traumatic brain
injury, ischemia and CNS diseases produce key inflam-
matory mediators including IL-6 [18]. TNF-a induces
other cytokines and it also plays important roles in ROS
production [11]. In addition, NADPH oxidase plays an
important role in the immune system in the brain [10].
However, the exact role of NADPH oxidase in astro-
cytes, not in neurons, remains to be fully clarified. The
present study suggests that NADPH oxidase regulates
the immune system in the CNS via regulation of IL-6
synthesis in astrocytes.
In conclusion, the current results strongly suggest that
TNF-a induces IL-6 synthesis through phosphorylation
of NFB at Ser 536 and Ser 468, and JAK-mediated
phosphorylation of STAT3 in addition to p38 MAP
kinase and SAPK/JNK in C6 glioma cells, and that oxi-
dative stress is associated with IL-6 synthesis.
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Figure 9 Effect of apocynin on TNF-a-induced the
phosphorylation of IB, NFB, MAP kinases and STAT3.
Cultured cells were pretreated with 0.1 mM apocynin for 60 min,
and then stimulated with 10 ng/ml TNF-a for 10 min (A) or 150
min (B). Cell extracts were analyzed by Western blotting using
antibodies against phospho-specific IB, phospho-specific NFB,
phospho-specific p38 MAP kinase, phospho-specific SAPK/JNK,
GAPDH, phospho-specific STAT3 or STAT3. Similar results were
obtained with two additional and different cell preparations.
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